Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1998
03/19/1998CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998CA2265861A1 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998CA2265670A1 Nucleosome-based anti-tumor compositions
03/19/1998CA2265631A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
03/19/1998CA2264938A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998CA2264829A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
03/19/1998CA2264825A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998CA2264646A1 Protein-lipid vesicles and autogenous vaccine comprising the same
03/19/1998CA2264541A1 Human protein kinases
03/18/1998EP0829540A1 Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor
03/18/1998EP0828854A1 Analytical and therapeutic agents
03/18/1998EP0828757A1 Helicobacter pylori antigens and vaccine compositions
03/18/1998EP0828756A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
03/18/1998EP0828520A1 Methods of screening compounds useful for prevention of infection or pathogenicity
03/18/1998EP0828511A1 Vaccine composition containing polyribosylribitol phosphate and method for making same
03/18/1998EP0828510A1 Abundant extracellular products and methods for their production and use
03/18/1998EP0828481A1 Oral dosage composition for intestinal delivery and method of use of the same
03/18/1998EP0739214B1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
03/18/1998EP0525119B1 Antibody conjugates for treatment of neoplastic disease
03/18/1998CN1176662A Identification of genes
03/18/1998CN1176659A A method for making heteromultimeric polypeptides
03/18/1998CN1176658A Vaccine and antitoxin for treatment and prevention of C. difficile disease
03/18/1998CN1176604A 乙肝疫苗 Hepatitis B vaccine
03/18/1998CN1176603A Vascular endothelial growth factor-B
03/18/1998CN1176391A Monoclonal antibodies against human interleukin-4 and hybridowas producing the same
03/18/1998CN1176139A Fowl Marek's disease vaccine sgnergist and its preparation
03/17/1998US5728677 Administering a specified polypeptide to a mammal
03/17/1998US5728578 Peptide of the structural phosphoprotein (pp 150) of human cytomegalovirus, and DNA encoding said peptide
03/17/1998US5728569 Inoculation of embryonated eggs, propagation, harvesting
03/17/1998US5728552 DNA encoding a fusion protein comprising a viral antigen and lymphokine
03/17/1998US5728537 Antigen immunogens for cancer detection in epithelial fluids
03/17/1998US5728520 Immunoreactive polypeptide compositions
03/17/1998US5728388 Contacting sample comprising tumor-sensitized cells with superantigens to produce stimulated cells, infusing into tumor bearing host
03/17/1998US5728387 Structural gene of pneumococcal protein
03/17/1998US5728386 Thermostable varicella zoster virus
03/17/1998US5728385 Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
03/17/1998US5728379 Tumor- or cell-specific herpes simplex virus replication
03/17/1998US5728369 Radioactive phosphorus labeling of proteins for targeted radiotherapy
03/17/1998CA1339760C Antihypertensive hyperimmine milk, prodiction, composition, and use
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/17/1998CA1339735C Cloning and sequencing of the major outer capsid gylcoprotein gene of a human rotavirus
03/17/1998CA1339732C Synthesis and immunogenicity of rotavirus genes using baculovirus expression system
03/17/1998CA1339730C Monoclonal antibiodies and methods for fungal pathogen detection
03/17/1998CA1339729C Human papillomavirus type 52 dna sequences and methods for employing thesame
03/17/1998CA1339724C Anti-inflammatory factor, method of isolation, and use
03/12/1998WO1998010284A1 Purification of antigen-specific t cells
03/12/1998WO1998010064A1 Iron regulated promoter and uses thereof
03/12/1998WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS
03/12/1998WO1998009990A1 Fungal antigens and process for producing the same
03/12/1998WO1998009650A1 Vaccinal preparations
03/12/1998WO1998009648A1 NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS
03/12/1998WO1998009647A2 Cyanidin compositions and therapeutic and diagnostic uses therefor
03/12/1998WO1998009646A1 A method for generating birnavirus from synthetic rna transcripts
03/12/1998WO1998004709A3 Herpes simplex virus ICP4 is an inhibitor of apoptosis
03/12/1998WO1998004585A3 Novel human macrophage antigen
03/12/1998WO1998000552A3 Receptor tyrosine phosphatase, and uses related thereto
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998WO1997046259A3 Chimeric toxin for targeted therapy
03/12/1998WO1997046204A3 Injectable compositions
03/12/1998WO1997041895A3 TREATMENT OF ASTHMA WITH TNFR-Ig
03/12/1998WO1997038087A3 Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
03/12/1998DE19638745A1 Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) Monoclonal antibodies against the extracellular domain of the human VEGF - receptor protein (KDR)
03/12/1998DE19636889A1 Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel Antineoplastic acting transferrin and albumin conjugates cytostatic compounds from the group of anthracyclines, alkylating agents, antimetabolites and cisplatin analogues and pharmaceutical compositions containing them
03/12/1998CA2639051A1 Fungal antigens and process for producing the same
03/12/1998CA2265883A1 Iron regulated promoter and uses thereof
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264486A1 Non-iga fc binding forms of the group b streptococcal beta antigens
03/12/1998CA2248001A1 Treatment of antigen presenting cells to modulate antigen presenting cell function
03/11/1998EP0827591A1 Method for diagnosing a patient for chlamydia
03/11/1998EP0827545A2 Retroviral vectors
03/11/1998EP0827509A1 Modulation of cholesteryl ester transfer protein (cetp) activity
03/11/1998EP0827502A1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
03/11/1998EP0827410A1 Method for introducing and expressing genes in animal cells
03/11/1998EP0827409A1 Compositions and methods for inhibiting xenograft rejection
03/11/1998EP0827396A1 Production scale method of forming microparticles
03/11/1998EP0666757B1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
03/11/1998CN1175958A Monoclonal antiidiotypic antibodies (AB2) and uses thereof
03/11/1998CN1175957A Monoclonal antibodies anti-CD6 and their uses
03/11/1998CN1175955A Helicobacter pylori antigen
03/11/1998CN1175954A Isolated nonapeptides presented by HLA molecules, and uses thereof
03/11/1998CN1175585A Double antigen contg hepatitis B virus and hepatitis C virus core antigen simultaneously
03/11/1998CN1175465A Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
03/10/1998US5726329 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
03/10/1998US5726304 Porphocyanine and CNC-expanded porphyrins
03/10/1998US5726298 Epimorphin and its encoding nucleic acids
03/10/1998US5726292 Immuno-potentiating systems for preparation of immunogenic materials
03/10/1998US5726286 Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains
03/10/1998US5726169 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
03/10/1998US5726166 Inositol monophosphate or a phosphatidyl inositol
03/10/1998US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
03/10/1998US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/10/1998US5725873 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
03/10/1998US5725863 Vaccine
03/10/1998US5725862 Vaccine for branhamelia catarrhalis
03/10/1998US5725861 Products and processes for gastric cascade and gastrointestinal disorder treatment with same
03/10/1998US5725860 Method for reducing the risk of developing diabetes
03/10/1998US5725858 Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein
03/10/1998US5725856 Anticarcinogenic agents and antitumor agents
03/10/1998US5725855 Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
03/10/1998US5725839 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
1 ... 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 ... 1823